Back

Suboptimal LDL cholesterol target achievement in cardiac ATTR amyloidosis despite disease-modifying therapy

30 August 2026 (14:15 - 15:00)
Organised by: Logo
Congress Presentation Part of: Lipid lowering (3) Drug therapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Marie Pollak

German Heart Centre Berlin, Berlin (Germany)

5 More presentations in this session

Presentation thumbnail
Improving LDL-C goal attainment: real-world outcomes and the impact of guideline optimization
Doctor R. Rached (DK)
Abstract Slides
Presentation thumbnail
Statin-free PCSK9 inhibitor therapy versus high-intensity atorvastatin for primary prevention: a target trial emulation study
Associate Professor C. Hsu (Taipei, TW)
Abstract Slides
Presentation thumbnail
Achievement of LDL‑C targets in clinical practice in Spain: a comparison between Observatory II and Observatory I
Doctor J. Cosin Sales (Valencia, ES)
Abstract Slides
Presentation thumbnail
Evolocumab for high cardiovascular risk patients without previous stroke: a network meta-analysis of randomized controlled trials
Mr S. Phutinart (Bangkok, TH)
Abstract Slides
Presentation thumbnail
Lipid-lowering therapy use and LDL-C goal achievement in patients with hypercholesterolaemia or mixed dyslipidaemia in Hong Kong: findings from a retrospective database study
Professor B. Yan (Hong Kong, CN)
Abstract Slides

Access the full session

Session thumbnail
Lipid lowering (3)

The Event

Event poster

ESC Congress 2026

30 August 2026 14:15 CET
You may be interested in
thumbnail
Congress Presentation
The current LDL-C target <1.4mmol/l of the ESC is achieved in less than 16% of patients with Coronary Heart Disease despite effective lipid-lowering therapy: Data from the LLT-R registry
28 August 2020
thumbnail
Congress Session
ATTR cardiomyopathy: from current practices to future treatment and monitoring
17 May 2025
thumbnail
Congress Presentation
LDL-cholesterol variability and cardiovascular follow-Up in sitosterolemia
1 September 2025
thumbnail
Congress Session
Essentials - beyond LDL: new targets and new treatments in lipid disorders
13 April 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources